| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | b-catenin ELISA Kit; Beta catenin ELISA Kit; Beta-catenin ELISA Kit; Cadherin associated protein ELISA Kit; Catenin (cadherin associated protein); beta 1; 88kDa ELISA Kit; Catenin beta 1 ELISA Kit; Catenin beta-1 ELISA Kit; CATNB ELISA Kit; CHBCAT ELISA Kit; CTNB1_HUMAN ELISA Kit; CTNNB ELISA Kit; CTNNB1 ELISA Kit; DKFZp686D02253 ELISA Kit; FLJ25606 ELISA Kit; FLJ37923 ELISA Kit; OTTHUMP00000162082 ELISA Kit; OTTHUMP00000165222 ELISA Kit; OTTHUMP00000165223 ELISA Kit; OTTHUMP00000209288 ELISA Kit; OTTHUMP00000209289 ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, cell culture supernates, tissue homogenates, cell lysates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
Catenin beta-1 (CTNNB1/CTNNB/OK/SW-cl.35/PRO2286) is a biological molecule commonly studied in cardiovascular research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P35222
Biological context
Researchers often monitor Catenin beta-1 (CTNNB1/CTNNB/OK/SW-cl.35/PRO2286) in serum, plasma, cell culture supernates, and tissue homogenates to better understand themes such as vascular biology and endothelial function, cardiac remodeling and injury responses, and thrombosis and hemostasis. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in Catenin beta-1 (CTNNB1/CTNNB/OK/SW-cl.35/PRO2286) may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, endothelial markers, coagulation-related proteins, and cardiac injury markers) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, Catenin beta-1 (CTNNB1/CTNNB/OK/SW-cl.35/PRO2286) may also appear under names such as b-catenin and Beta catenin. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Catenin beta-1 (CTNNB1/CTNNB/OK/SW-cl.35/PRO2286) participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
LncRNA-GAS5 and β-Catenin as Independent Predictors of Asymptomatic Organ Damage in Nondiabetic Hypertensive Patients
MM Esawy,ACS omega,2023
Exercise intervention lowers aberrant serum WISP-1 levels with insulin resistance in breast cancer survivors: a randomized controlled trial
JS Chang,Scientific Reports,2020
Serum Expression of β-Catenin Is a Potential Detection Marker in Patients with Colorectal Cancer
Shue Li, et al,Disease Markers,2019
Silencing GSK3β instead of DKK1 can inhibit osteogenic differentiation caused by co-exposure to fluoride and arsenic
Zeng Q, et al,Bone,2019
Identification of serum β-catenin as a biomarker in patients with HBV-related liver diseases
Duan L.et al,Journal of Translational Medicine,2018
Sclerostin levels associated with inhibition of the Wnt/ß-catenin signaling and reduced bone turnover in type 2 diabetes mellitus
Gaudio A et al,J Clin Endocrinol Metab,2012